🌍·1d agodiscovery
Sanofi-backed Expedition uses $115M series B to advance COPD drug on phase 2 journey
Publisher
f
fiercebiotech.com
Global
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- fiercebiotech.com
- Region
- Global
- Scope
- discovery
- Published
- August 5, 2026
- Language
- EN
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on news.google.com
Leave the platform to read the original full article on the publisher site.
Source: fiercebiotech.com
Scope: discovery
Related coverage
More related coverage
Pharmaceutical Executive/3h ago
Mergers as Strategic Architecture: Rethinking How to Evaluate the AstraZeneca–BMS Rumors
fiercebiotech.com/3h ago
Context scraps bispecific T-cell engager program to extend cash runway deeper into 2027
koreabiomed.com/3h ago
Onconic’s GERD drug Jaqbo wins first overseas approval in India
pharmaphorum/3h ago